Skip to main content

JANE STREET GROUP, LLC

Position in RLMD — Relmada Therapeutics, Inc.

CIK 1595888 NEW YORK, NY

Position in RLMD

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$1,544,903
+$235,447 QoQ
Shares Held
221,969
-18.1% QoQ
Ownership
0.212%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in RLMD Over Time

Shares Held

Position Value (USD)

Derivatives in RLMD

reported options exposure · as of Mar 31, 2026
CallValue
$75,864
CallShares
10,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,255,284,514 across 317 Biotechnology names. RLMD ranks #98 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RLMD

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $75,864 10,900
2026-03-31 $1,544,903 221,969
2025-12-31 $1,309,456 271,109
2025-12-31 $58,926 12,200
2025-09-30 $172,190 85,667
2025-06-30 $68,612 114,354
2024-06-30 $112,428 37,476
2024-03-31 $814,814 175,229
2023-12-31 $50,238 12,135
2023-06-30 $29,810 12,118
2022-12-31 $413,853 118,583
2022-06-30 $234,487 12,348
2022-03-31 $1,504,503 55,743
2022-03-31 $933,854 34,600
2021-06-30 $701,019 21,900
2021-06-30 $605,596 18,919
2020-12-31 $907,581 28,300
2020-06-30 $2,009,275 44,900
2020-06-30 $836,735 18,698
2020-03-31 $270,696 7,936